"Heterologous human/rat HER2-specific exosome-targeted T cell vaccine stimulates potent humoral and CTL responses leading to enhanced circumvention of HER2 tolerance in double transgenic HLA-A2/HER2 mice"
Authors: Xie Y, Wu J, Xu A, Ahmeqd S, Sami A, Chibbar R, Freywald A, Zheng C, Xiang J.
Vaccine. 2018 Mar 7;36(11):1414-1422. doi: 10.1016/j.vaccine.2018.01.078. Epub 2018 Feb 5. PMID: 29415817
The paper can be accessed here: https://www.ncbi.nlm.nih.gov/pubmed/29415817
Share this story